Fangdie Ye
-
- Cancer-related molecular mechanisms research 5
- Cancer, Lipids, and Metabolism 4
-
- Ferroptosis and cancer prognosis 17
- Renal cell carcinoma treatment 3
-
- Epigenetics and DNA Methylation 9
- RNA modifications and cancer 6
- Metabolomics and Mass Spectrometry Studies 3
-
- Bladder and Urothelial Cancer Treatments 11
- Journals
- Frontiers in Immunology (4 papers)Aging (2 papers)Functional & Integrative Genomics (2 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Fangdie Ye
34 papers receiving 390 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 154
- Pulmonary and Respiratory Medicine 151
- Oncology 93
- Molecular Biology 223
- Immunology 61
Countries citing papers authored by Fangdie Ye
This map shows the geographic impact of Fangdie Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangdie Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangdie Ye more than expected).
Fields of papers citing papers by Fangdie Ye
This network shows the impact of papers produced by Fangdie Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangdie Ye. The network helps show where Fangdie Ye may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fangdie Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 15 | |
| 10 | 2023 | 15 | |
| 11 | 2023 | 20 | |
| 12 | 2023 | 18 | |
| 13 | 2022 | 3 | |
| 14 | 2022 | 12 | |
| 15 | 2022 | 19 | |
| 16 | 2021 | 10 | |
| 17 | 2021 | 2 | |
| 18 | 2021 | 36 | |
| 19 | 2021 | 31 | |
| 20 | 2021 | 20 |
About Fangdie Ye
Fangdie Ye is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Urology and Surgery, having authored 34 papers that have together received 395 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (17 papers), Bladder and Urothelial Cancer Treatments (11 papers), Epigenetics and DNA Methylation (9 papers), RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers), Cancer, Lipids, and Metabolism (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Cancer Research (154 citations), Pulmonary and Respiratory Medicine (151 citations), Oncology (93 citations), Molecular Biology (223 citations) and Immunology (61 citations). Fangdie Ye has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Yufei Liu, Haowen Jiang, Chen Yang, Yingchun Liang, Yuxi Ou, Quan Zhou, Haowen Jiang, Yun Hu, Jiahao Gao and Chenyang Xu. Their work appears in journals such as Frontiers in Immunology, Aging, Functional & Integrative Genomics, Environmental Toxicology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.